2HX-19812-55068
2 vaccinations
4 coded responses
15 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 981 / WA
- Registered
- 2021-03-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-19
Dose 1 — Pfizer-BioNTech
-
2021-03-06
Registered in v-safe
-
2021-03-06
Survey response — day 14, dose 1MedDRA: Arthralgia, Fatigue, Pain in extremity, Periarthritis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Joint pain in shoulders, wrists, thumbs; frozen shoulder symptoms on right side; more fatique than usual.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Report sent to call center — day 14, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-12
Dose 2 — Pfizer-BioNTech
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Fatigue or tirednessAdult check-in
-
2021-03-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Fatigue or tirednessAdult check-in
-
2021-03-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-19
Health check-in — day 7, dose 2Feeling: Poor · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-26
- 2021-04-02
-
2021-04-10
Survey response — day 28, dose 2MedDRA: Arthralgia, Mobility decreased, Myalgia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Joint and muscle pain and mobility problems that started within 12 hours of vaccine 1 are worse. I am functioning at about 50% of normal. Shoulders, knees and wrist/hands are affected.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Survey response — day 35, dose 2MedDRA: Muscular weakness — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Muscle strength continues to decline.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-23
- 2021-06-11
- 2021-09-15
- 2022-02-16
-
2022-02-23
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-03-12
Survey response — 12 months, dose 2MedDRA: Ocular hypertension, Office visit — Feeling: GoodFree text: My eye pressure is increasing so glaucomaconcern. Eye doctor says it is due to the steroids I'm still taking to treat the effects of the shot.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-19 | Pfizer-BioNTech | |
| 2 | 2021-03-12 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
1 wait over 3 months for a first call
Free text
Release 5 — day 14, dose 1
Symptoms: Joint pain in shoulders, wrists, thumbs; frozen shoulder symptoms on right side; more fatique than usual.
Release 7 — day 28, dose 2
Symptoms: Joint and muscle pain and mobility problems that started within 12 hours of vaccine 1 are worse. I am functioning at about 50% of normal. Shoulders, knees and wrist/hands are affected.
Release 7 — day 35, dose 2
Symptoms: Muscle strength continues to decline.
Release 11 — 12 months, dose 2
Symptoms: My eye pressure is increasing so glaucomaconcern. Eye doctor says it is due to the steroids I'm still taking to treat the effects of the shot.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Mobility decreased | ✓ | ✓ | ✓ |
| SD | Muscular weakness | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Ocular hypertension | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Pain in extremity | ✓ | ✓ | ✓ |
| SD | Periarthritis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release